Trimas Corporation · NASDAQ:TRS
Trimas — BWS Investor Conference (August 2026)
27 slides from Trimas's conference presentation, Aug 25, 2026
Slide 1: BWS Investor Conference
BWS Investor Conference August 25, 2026
Slide 2: Disclaimer
Disclaimer Forward-Looking Statements Any "forward-looking" statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, contained herein, including those relating to TriMas’ business, financial condition or future results, invol
Slide 3: TriMas Overview
— TriMas Overview
Slide 4: TriMas Overview: A High-Quality, Scalable Precision Manufacturing Platform
TriMas Overview A High-Quality, Scalable Precision Manufacturing Platform Who We Are: Packaging TriMas Global designer and manufacturer of high-value, precision-engineered products Innovation-driven, quality-focused platform serving diversified consumer products, life sciences and industrial end
Slide 5: The New TriMas
The New TriMas Enhanced Focus. Stronger Foundation. New Opportunity. Who We Are: Global provider of high-value dispensing, closure and life science solutions Deep technical expertise with long-standing customer partnerships Diversified end-market exposure that supports resilient demand Flexi
Slide 6: TriMas Packaging Product Overview
TriMas Packaging Product Overview High-Performance Solutions Across Diverse Markets Fragrance Pumps All Plastic Solutions Food Caps Push-Pull Caps Press-Fit Closures AVDS (Airless High-viscosity Dispensing System) Color Cosmetics Foamer Pumps Aseptic Tethered Caps Child-Resistant Caps Pull-Out Spout
Slide 7: TriMas Global Footprint
TriMas Global Footprint North America Asia Europe South America ~2,500 employees Sales by Geography Australia Europe 28 facilities U.S. Asia 12 countries Other TriMas Headquarters Manufacturing Facilities Sales Branch/Tech/Distribution Locations 7
Slide 8: A Differentiated Growth Platform
A Differentiated Growth Platform Manufacturing DNA Sustainability Leadership Deep expertise in precision injection molding and engineered Innovation-led sustainability and lightweighting solutions packaging solutions without compromising performance Proven ability to manufacture complex, high-
Slide 9: What's Next: Multiple Levers for Growth
What’s Next: Multiple Levers for Growth Revitalized Organization Focused on Driving Meaningful Shareholder Value Acquisition Growth New Product Innovation • Target strategic acquisitions aligned with high-growth, high- margin packaging and life sciences platforms • Accelerate customer-driven innovat
Slide 10: Q2 2026 Earnings
— Q2 2026 Earnings
Slide 11: Opening Remarks
Opening Remarks Q2 2026: Executing Our Plan and Driving Improved Performance Delivering Operational Improvement Previously announced cost-reduction initiatives on track and contributing to year-over-year profit improvement Advancing operational excellence and standardization efforts to improve s
Slide 12: Second Quarter 2026 Results – Continuing Operations
Second Quarter 2026 Results – Continuing Operations Q2 Net Sales Q2 Operating Profit Q2 Earnings Q2 2026 Results (in millions) (in millions) Per Share(1) Sales increased 1.6%, supported by Q2 Results favorable foreign currency translation $174.6 +1.6% $0.52 +160.0% $171.8 Operating profit increa
Slide 13: Balance Sheet & Capitalization
Balance Sheet & Capitalization Net Cash Position Provides Future Financial Flexibility Strong balance sheet following the TriMas Aerospace divestiture, with a net cash position of $846 million Cash currently invested in interest-bearing accounts, June 30, December 31, June 30, generating attract
Slide 14: Segment Overview: Packaging
Segment Overview: Packaging Adjusted for Special Items Q2 2026 Q2 2025 Change Q2 YTD Net Sales $142.9 $143.0 -0.1% $282.1 Operating Profit $21.2 $20.4 3.7% $38.9 Operating Margin 14.8% 14.3% 50 b ps 13.8% (1) Adjusted EBITDA $29.6 $30.0 -1.1% $55.1 Adjusted EBITDA Margin 20.7% 20.9% -20 b ps 19.5% T
Slide 15: Segment Overview: Specialty Products
Segment Overview: Specialty Products Adjusted for Special Items Q2 2026 Q2 2025 Change Q2 YTD Net Sales $31.7 $28.7 10.2% $60.8 Operating Profit $0.7 $1.3 n/m $3.6 Operating Margin 2.2% 4.4% -220 bps 5.8% Adjusted EBITDA(1) $1.5 $2.1 -27.8% $5.1 Adjusted EBITDA Margin 4.8% 7.3% -250 bps 8.4% Takeawa
Slide 16: Forward Expectations – from Continuing Operations
Forward Expectations – from Continuing Operations As of July 30, 2026 Full Year 2026 Outlook SALES GROWTH ADJUSTED OPERATING PROFIT ADJUSTED EPS(1) 3% to 6% MARGIN $1.60 to $1.70 IMPROVEMENT (FY 2025: $645.7M) 300+ BPS (FY 2025: $0.55) (FY 2025: 5.3%) (Raised from $1.50 to $1.70) Full Year 2026 Assu
Slide 17: Levers for Long-term Value Creation
Levers for Long-term Value Creation Continuous Improvement Innovation Capital Allocation Portfolio Shaping • Accelerate customer-driven • Pursue strategic, high-quality • Focus on highest-value products and • Embed Operational Excellence through Lean, Six Sigma and product innovation to address acqu
Slide 18: Appendix
— Appendix
Slide 19: Level-Setting RemainCo (Continuing Operations)
Level-Setting RemainCo (Continuing Operations) Full Year 2025 Basis ($ in millions, except per share amount) Packaging $ % of Sales Packaging 2026 Focus Areas Net Sales $535.5 • Streamline commercial and operational functions to reduce complexity and cost, unify brands, and further integrate prior a
Slide 20: Condensed Consolidated Balance Sheet
Condensed Consolidated Balance Sheet June 30, December 31, 2026 2025 Assets Current assets: Cash and cash equivalents $ 1,242,480 $ 30,020 Receivables, net 153,640 111,270 Inventories 116,530 108,720 Prepaid expenses and other current assets 34,510 36,380 Current assets, discontinued operations - 17
Slide 21: Consolidated Statement of Income
Consolidated Statement of Income Three months ended Six months ended June 30, June 30, 2026 2025 2026 2025 Net sales $ 174,580 $ 171,750 $ 342,860 $ 324,210 Cost of sales (139,240) (133,800) (270,650) (253,430) Gross profit 35,340 37,950 72,210 70,780 Selling, general and administrative expenses (24
Slide 22: Consolidated Statement of Cash Flows
Consolidated Statement of Cash Flows Six months ended June 30, 2026 2025 Cash Flows from Operating Activities: Income from continuing operations 15,510 4,350 Income from discontinued operations 798,690 24,790 Net income 814,200 29,140 Adjustments to reconcile net income to net cash provided by (used
Slide 23: Company and Segment Financial Information
Company and Segment Financial Information Continuing Operations Three months ended Six months ended June 30, June 30, YOY Growth % 2026 2025 2026 2025 Organic Acquisitions Divestitures Fx Total Packaging Q2 2026 vs. Q2 2025 Net sales $ 142,920 $ 143,010 $ 282,090 $ 270,580 Operating profit $ 18,720
Slide 24: Additional Information on Non-GAAP Measures
Additional Information on Non-GAAP Measures Continuing Operations Three months ended Six months ended June 30, June 30, 2026 2025 2026 2025 Income from continuing operations, as reported $ 67,270 $ 2,410 $ 15,510 $ 4,350 Special Items to consider in evaluating quality of net income from continuing o
Slide 25: Additional Information on Non-GAAP Measures
Additional Information on Non-GAAP Measures Continuing Operations Three months ended June 30, 2026 2025 As reported Special Items As adjusted As reported Special Items As adjusted Net cash provided by (used for) operating activities $ (38,520) $ 33,580 $ (4,940) $ 16,450 $ 3,410 $ 19,860 Less: Capit
Slide 26: Additional Information on Non-GAAP Measures
Additional Information on Non-GAAP Measures Continuing Operations Three months ended Twelve months ended Six months ended June 30, June 30, June 30, From Continuing Operations 2026 2025 2026 2025 2026 2025 Income from continuing operations, as reported $ 67,270 $ 2,410 $ 83,470 $ (1,160) $ 15,510 $
Slide 27: Additional Information on Non-GAAP Measures
Additional Information on Non-GAAP Measures As of July 30, 2026 Full Year 2026 GAAP to Non-GAAP EPS Outlook Reconciliation Twelve months ended December 31, 2026 Continuing Operations Low High Diluted earnings per share (GAAP) $ 1.08 $ 1.18 Pre-tax amortization of acquisition-related intangible asset